Accessibility Menu
 
Cdt Equity logo

Cdt Equity

(NASDAQ) CDT

Current Price$4.07
Market Cap$19.27M
Since IPO (2022)-100%
5 YearN/A
1 Year-100%
1 Month-72%

Cdt Equity Financials at a Glance

Market Cap

$19.27M

Revenue (TTM)

$2.72B

Net Income (TTM)

$237.52M

EPS (TTM)

$-10302.10

P/E Ratio

0.00

Dividend

$0.00

Beta (Volatility)

0.58 (Low)

Price

$4.07

Volume

146,737.196

Open

$5.94

Previous Close

$4.08

Daily Range

$3.71 - $5.94

52-Week Range

$3.64 - $3030.00

CDT News

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Cdt Equity

Industry

Life Sciences Tools and Services

Employees

6

CEO

Andrew Regan, PhD

Headquarters

Naples, FL 34103, US

CDT Financials

Key Financial Metrics (TTM)

Gross Margin

38%

Operating Margin

12%

Net Income Margin

9%

Return on Equity

0%

Return on Capital

11%

Return on Assets

7%

Earnings Yield

N/A

Dividend Yield

0.00%

Payout Ratio

3.35%

Stock Overview

Market Cap

$19.27M

Shares Outstanding

4.72M

Volume

146.74K

Short Interest

0.00%

Avg. Volume

71.08K

Financials (TTM)

Gross Profit

$1.03B

Operating Income

$315.69M

EBITDA

$371.52M

Operating Cash Flow

$354.86M

Capital Expenditure

$136.17M

Free Cash Flow

$218.69M

Cash & ST Invst.

$389.89M

Total Debt

$1.29B

Cdt Equity Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q4 2025YOY CHG

Revenue

$2.72B

N/A

Gross Profit

$1.03B

+228431.2%

Gross Margin

38.01%

N/A

Market Cap

$19.27M

N/A

Market Cap/Employee

$3.21M

N/A

Employees

6

N/A

Net Income

$255.42M

+10716.0%

EBITDA

$387.32M

+39066.2%

Quarterly Fundamentals

Name
Q4 2025YOY CHG

Net Cash

$895.78M

-346.9%

Accounts Receivable

$462.85M

+94551.3%

Inventory

$402.35M

+17.3%

Long Term Debt

$1.29B

+1201457.0%

Short Term Debt

$0.00

-100.0%

Return on Assets

6.70%

N/A

Return on Invested Capital

11.09%

N/A

Free Cash Flow

$180.71M

+4839.3%

Operating Cash Flow

$245.00M

+6525.3%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
LIXTLixte Biotechnology Holdings, Inc.
$3.05+5.17%
COCHEnvoy Medical, Inc.
$0.61-6.12%
ZVSAZyVersa Therapeutics, Inc.
$0.20+5.79%
ENVBEnveric Biosciences, Inc.
$1.96-3.71%

Trending Stocks

Symbol / CompanyPricePrice Chg
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares
$10.61+0.02%
CRWVCoreWeave
$102.00+0.11%
NOKNokia
$9.46-0.01%
NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF
$6.44-0.05%

Questions About CDT

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.